Publication | Closed Access

Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

MedicineCell TraffickingCell-matrix InteractionHuman TrailTumor TargetingCell BiologyIntracellular TraffickingCancer BiologyRadiation OncologyTumor MicroenvironmentTumor BiologyAlbumin-binding DomainCirculatory Half-life